跳至主要内容
临床试验/ISRCTN58592532
ISRCTN58592532已完成未知

Pharmacological treatment of nystagmus: a randomised double-masked, placebo-controlled crossover study using gabapentin and memantine

niversity Hospitals of Leicester (UK)0 个研究点目标入组 180 人开始时间: 2007年12月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients with congenital or acquired nystagmus
  • 2. Over the age of 16 years

排除标准

  • 1. Contraindication for gabapentin or memantine such as epilepsy, renal impairment, pregnancy or breast-feeding
  • 2. For women of childbearing potential, a pregnancy test will be performed and documentation of adequate contraception during the study drug administration will be obtained
  • 3. Patients on medication incompatible with gabapentin or memantine, such as amantadin

研究者

发起方
niversity Hospitals of Leicester (UK)

相似试验